The Need for a Coagulation Assay after Initiation of New Oral Anticoagulants in Patients with Renal Dysfunction: A Case Report

BACKGROUND: Dabigatran etexilate, a new oral anticoagulant, was recently approved as an efficacious alternative to warfarin for the prevention of first and recurrent stroke in patients with nonvalvular atrial fibrillation. Limited data are available for dabigatran use in patients with a creatinine c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Mi Ji, Jang, Hye Min, Jeong, Woo Kyo, Bang, Oh Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neurological Association 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596111/
https://www.ncbi.nlm.nih.gov/pubmed/25749821
http://dx.doi.org/10.3988/jcn.2015.11.4.395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596111/
https://www.ncbi.nlm.nih.gov/pubmed/25749821
http://dx.doi.org/10.3988/jcn.2015.11.4.395

Ejemplares similares